State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2.
Arch Med Sci
; 16(3): 508-518, 2020.
Article
in En
| MEDLINE
| ID: mdl-32399096
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Arch Med Sci
Year:
2020
Type:
Article
Affiliation country:
Saudi Arabia